Heidelberg Engineering licenses Mass General's OCT technology for ophthalmology

Heidelberg Engineering (Carlsbad, CA) has entered into a patent license agreement with Massachusetts General Hospital (MGH; Boston, MA), granting global and exclusive rights to 77 basic patents and patent applications relating to swept-source optical coherence tomography (OCT) technology for ophthalmology.

Spectral-domain OCT has become indispensable to eye care professionals worldwide to diagnose and follow-up patients with diseases of the posterior segment of the eye, such as age-related macular degeneration (AMD), diabetic retinopathy, or glaucoma. But swept-source OCT technology has specific characteristics that are ideal for acquiring comprehensive information about a wide variety of properties of the anterior part of the eye, especially of patients who have to undergo cataract or refractive surgery.

Along with the patent license agreement, MGH’s Wellman Center for Photomedicine and Heidelberg Engineering have established a long-term relationship on OCT research. The company is supporting the research, which is being led by one of the inventors of the swept-source OCT technology, Brett E. Bouma, Ph.D., Associate Physicist in the Wellman Center for Photomedicine at the Massachusetts General Hospital and professor at Harvard Medical School. The intent of both partners is to transfer future research results into clinically relevant concepts and products.

The company will introduce a new swept-source technology-based platform product to examine the anterior segment of the eye, says Dr. Tilman Otto, head of research and development at Heidelberg Engineering.

For more information, please visit www.heidelbergengineering.com.

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

Optical brain imaging noninvasively measures small perfusion changes caused by visual stimulation

An optical brain imaging system can track very small, focal changes in cortical perfusion resulting from visual stimulation.

Optical Coherence Tomography: Beyond better clinical care: OCT's economic impact

The optical coherence tomography (OCT) industry has grown dramatically in its first 25 years.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS